###
中国临床研究英文版:2026,39(8):1181-1185
本文二维码信息
码上扫一扫!
PLAGL2、PLXDC2在胃癌组织中的表达变化及其临床意义
(邯郸市第一医院普外科, 河北 邯郸 056000)
The expression changes and clinical significance of PLAGL2 and PLXDC2 in gastric cancer tissues
(Department of General Surgery,Handan First Hospital,Handan,Hebei 056000,China)
摘要
本文已被:浏览 285次   下载 232次
Received:September 17, 2025   Published Online:August 25, 2026
中文摘要: 目的 探讨胃癌组织中多形性腺瘤基因样2(PLAGL2)、含丛蛋白结构域2(PLXDC2)的表达情况,并分析其与临床病理参数及患者预后的关联。方法 选取邯郸市第一医院2019年5月至2021年5月收治的行胃切除术的104例胃癌患者为研究对象,采集患者手术或内镜切除的胃癌组织及配对癌旁组织,利用免疫组织化学法检测PLAGL2、PLXDC2蛋白表达;分析二者与胃癌临床病理特征的关联。随访3年,记录患者生存情况。运用多因素Cox 回归评估3 年总生存期的影响因素。结果 PLAGL2、PLXDC2 在胃癌组织中的高表达占比(73.08%、75.96%)高于癌旁组织中的高表达占比(20.19%、16.35%)(P<0.05)。PLAGL2和PLXDC2表达与胃癌患者分化程度、浸润深度、淋巴结转移及TNM分期显著相关(P<0.05)。低分化、深肌层浸润(T3~T4)、有淋巴结转移、TNM分期Ⅲ~Ⅳ期、PLAGL2高表达、PLXDC2高表达的患者3年总生存期较短(P<0.05),且均为影响3年总生存期的危险因素(P<0.05)。PLAGL2高表达胃癌患者的3年总生存率为22.37%(17/76),低于PLAGL2低表达胃癌患者的53.57%(15/28)(χ2=9.352,P=0.002);PLXDC2高表达胃癌患者的3年总生存率为22.78%(18/79),低于PLXDC2低表达胃癌患者的56.00%(14/25)(χ2=9.835,P=0.002)。结论 胃癌组织中PLAGL2、PLXDC2均呈高表达,其蛋白表达与胃癌恶性病理特征(低分化、深肌层浸润、有淋巴结转移及TNM分期Ⅲ~Ⅳ期)有关,二者高表达者3年总生存期明显缩短,预后较差。
Abstract:Objective To investigate the expression of pleomorphic adenoma gene like-2(PLAGL2)and plexin-domain containing 2(PLXDC2)in gastric cancer tissues,and to analyze their association with clinical and pathological parameters and patient prognosis. Methods A total of 104 gastric cancer patients undergoing gastrectomy at Handan First Hospital from May 2019 to May 2021 were selected. Gastric cancer tissues and matched adjacent normal tissues resected from patients via surgery or endoscopy were collected,and PLAGL2 and PLXDC2 protein expression were detected using immunohistochemistry. The association between these two proteins and the clinical and pathological characteristics of gastric cancer was analyzed. Patients were followed up for 3 years,and their survival status was recorded. Multivariate Cox regression was used to evaluate the factors influencing 3-year overall survival. Results The proportions of high PLAGL2 and PLXDC2 expression in gastric cancer tissues(73.08%,75.96%)were higher than those in adjacent tissues(20.19%,16.35%)(P<0.05). The expressions of PLAGL2 and PLXDC2 were significantly correlated with the differentiation degree,depth of invasion,lymph node metastasis and TNM stage in gastric cancer patients(P<0.05). Patients with poorly differentiated,deep muscular invasion(T3-T4),lymph node metastasis,TNM stage Ⅲ-Ⅳ,high expression of PLAGL2,and high expression of PLXDC2 had shorter 3-year overall survival(P<0.05),and all of these were risk factors affecting 3-year overall survival(P<0.05). The 3-year overall survival rate of gastric cancer patients with high PLAGL2 expression was 22.37%(17/76),lower than 53.57%(15/28)in patientswithlowPLAGL2expression(χ2=9.352,P=0.002);the 3-year overall survival rate of gastric cancer patients with high PLXDC2 expression was 22.78%(18/79),lower than 56.00%(14/25)in patients with low PLXDC2 expression(χ2=9.835,P=0.002). Conclusion PLAGL2 and PLXDC2 are both highly expressed in gastric cancer tissues,and their protein expression is associated with the malignant pathological characteristics of gastric cancer(poorly differentiated,deep muscular invasion,lymph node metastasis,and TNM stages Ⅲ-Ⅳ). Patients with high expression of both proteins have a significantly shorter 3-year overall survival and a poorer prognosis.
文章编号:     中图分类号:R735.2    文献标志码:A
基金项目:邯郸市科学技术研究与发展计划项目(22422083057ZC)
引用文本:


Scan with WeChat

Scan with WeChat